SLC5A2 and diabetic kidney disease: Although we are aware that these observations require further validation with regard to protein expression and experimental models, here we link SGLT-2 and intrarenal synthesis of complement C5 in diabetic nephropathy, as it has also been recently described in experimental lupus nephritis [20].